Kinetochore protein MAD1 participates in the DNA damage response through ataxia-telangiectasia mutated kinase-mediated phosphorylation and enhanced interaction with KU80. 2020

Mingming Xiao, and Xuesong Li, and Yang Su, and Zhuang Liu, and Yamei Han, and Shuai Wang, and Qinghua Zeng, and Hong Liu, and Jianwei Hao, and Bo Xu
Department of Biochemistry and Molecular Biology, Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.

Objective: Mitotic arrest-deficient protein 1 (MAD1) is a kinetochore protein essential for the mitotic spindle checkpoint. Proteomic studies have indicated that MAD1 is a component of the DNA damage response (DDR) pathway. However, whether and how MAD1 might be directly involved in the DDR is largely unknown. Methods: We ectopically expressed the wild type, or a phosphorylation-site--mutated form of MAD1 in MAD1 knockdown cells to look for complementation effects. We used the comet assay, colony formation assay, immunofluorescence staining, and flow cytometry to assess the DDR, radiosensitivity, and the G2/M checkpoint. We employed co-immunoprecipitation followed by mass spectrometry to identify MAD1 interacting proteins. Data were analyzed using the unpaired Student's t-test. Results: We showed that MAD1 was required for an optimal DDR, as knocking down MAD1 resulted in impaired DNA repair and hypersensitivity to ionizing radiation (IR). We found that IR-induced serine 214 phosphorylation was ataxia-telangiectasia mutated (ATM) kinase-dependent. Mutation of serine 214 to alanine failed to rescue the phenotypes of MAD1 knockdown cells in response to IR. Using mass spectrometry, we identified a protein complex mediated by MAD1 serine 214 phosphorylation in response to IR. Among them, we showed that KU80 was a key protein that displayed enhanced interaction with MAD1 after DNA damage. Finally, we showed that MAD1 interaction with KU80 required serine 214 phosphorylation, and it was essential for activation of DNA protein kinases catalytic subunit (DNA-PKcs). Conclusions: MAD1 serine 214 phosphorylation mediated by ATM kinase in response to IR was required for the interaction with KU80 and activation of DNA-PKCs.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011836 Radiation Tolerance The ability of some cells or tissues to survive lethal doses of IONIZING RADIATION. Tolerance depends on the species, cell type, and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS. Radiation Sensitivity,Radiosensitivity,Sensitivity, Radiation,Tolerance, Radiation,Radiation Sensitivities,Radiation Tolerances,Radiosensitivities,Sensitivities, Radiation,Tolerances, Radiation
D011839 Radiation, Ionizing ELECTROMAGNETIC RADIATION or particle radiation (high energy ELEMENTARY PARTICLES) capable of directly or indirectly producing IONS in its passage through matter. The wavelengths of ionizing electromagnetic radiation are equal to or smaller than those of short (far) ultraviolet radiation and include gamma and X-rays. Ionizing Radiation,Ionizing Radiations,Radiations, Ionizing
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D005260 Female Females
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Mingming Xiao, and Xuesong Li, and Yang Su, and Zhuang Liu, and Yamei Han, and Shuai Wang, and Qinghua Zeng, and Hong Liu, and Jianwei Hao, and Bo Xu
December 2007, Molecular cancer research : MCR,
Mingming Xiao, and Xuesong Li, and Yang Su, and Zhuang Liu, and Yamei Han, and Shuai Wang, and Qinghua Zeng, and Hong Liu, and Jianwei Hao, and Bo Xu
February 2005, Cancer science,
Mingming Xiao, and Xuesong Li, and Yang Su, and Zhuang Liu, and Yamei Han, and Shuai Wang, and Qinghua Zeng, and Hong Liu, and Jianwei Hao, and Bo Xu
January 2011, PloS one,
Mingming Xiao, and Xuesong Li, and Yang Su, and Zhuang Liu, and Yamei Han, and Shuai Wang, and Qinghua Zeng, and Hong Liu, and Jianwei Hao, and Bo Xu
December 2012, The Yale journal of biology and medicine,
Mingming Xiao, and Xuesong Li, and Yang Su, and Zhuang Liu, and Yamei Han, and Shuai Wang, and Qinghua Zeng, and Hong Liu, and Jianwei Hao, and Bo Xu
December 2001, Cancer research,
Mingming Xiao, and Xuesong Li, and Yang Su, and Zhuang Liu, and Yamei Han, and Shuai Wang, and Qinghua Zeng, and Hong Liu, and Jianwei Hao, and Bo Xu
November 2011, Nucleic acids research,
Mingming Xiao, and Xuesong Li, and Yang Su, and Zhuang Liu, and Yamei Han, and Shuai Wang, and Qinghua Zeng, and Hong Liu, and Jianwei Hao, and Bo Xu
April 2010, The Journal of biological chemistry,
Mingming Xiao, and Xuesong Li, and Yang Su, and Zhuang Liu, and Yamei Han, and Shuai Wang, and Qinghua Zeng, and Hong Liu, and Jianwei Hao, and Bo Xu
July 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Mingming Xiao, and Xuesong Li, and Yang Su, and Zhuang Liu, and Yamei Han, and Shuai Wang, and Qinghua Zeng, and Hong Liu, and Jianwei Hao, and Bo Xu
February 2012, DNA repair,
Mingming Xiao, and Xuesong Li, and Yang Su, and Zhuang Liu, and Yamei Han, and Shuai Wang, and Qinghua Zeng, and Hong Liu, and Jianwei Hao, and Bo Xu
October 2018, European journal of cancer (Oxford, England : 1990),
Copied contents to your clipboard!